- Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man
[作者:Hendriks, RW; Bredius, RGM; Pike-Overzet, K; Staal, FJT,期刊:Expert Opinion on Therapeutic Targets, 页码:1003-1021 , 文章类型: Review,,卷期:2011年15-8]
- Introduction: X-linked agammaglobulinemia (XLA) is the most common primary immunodeficiency in man, and is caused by a single genetic defect. Inactivating mutations in the Bruton's tyrosine kinase (BTK) gene are invariab...
- HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
[作者:Nogueira-Machado, JA; Volpe, CMD; Veloso, CA; Chaves, MM,期刊:Expert Opinion on Therapeutic Targets, 页码:1023-1035 , 文章类型: Review,,卷期:2011年15-8]
- Introduction: Despite advances in treatment of diabetes mellitus, its prevalence continues to rise globally. Medications available are unable to control the vascular complications. Proposals for new therapeutic targets m...
- The Therapeutic Target Database: an Internet resource for the primary targets of approved, clinical trial and experimental drugs
[作者:Liu, X; Zhu, F; Ma, XH; Tao, L; Zhang, JX; Yang, SY; Wei, YQ; Chen, YZ,期刊:Expert Opinion on Therapeutic Targets, 页码:903-912 , 文章类型: Editorial Material,,卷期:2011年15-8]
- Increasing numbers of proteins, nucleic acids and other molecular entities have been explored as therapeutic targets. A challenge in drug discovery is to decide which targets to pursue from an increasing pool of potentia...
|